Savara Inc. (NASDAQ:SVRA) Q2 2020 Earnings Conference Call - Final Transcript

Aug 06, 2020 • 04:30 pm ET

Previous

Savara Inc. (NASDAQ:SVRA) Q2 2020 Earnings Conference Call - Final Transcript

Share
Close

Loading Event

Loading Transcript

Q & A
Executive
David Lowrance

the patients syndrome.

Given enrolled patients in IMPALA 2 with similar disease severity, as was an IMPALA. In IMPALA, there was a noted improvement on the - surface change after a whole lung lavage. However, the improvement was for limited duration, and the patients disease progress. We anticipate that to change in IMPALA 2.

Executive
Anne Erickson

Thank you, Jason. Are there any other questions?

Operator
Operator

No, there are no more questions in the queue.

Executive
Robert Neville

Okay. Okay. Thank you. Thank you, Jason, and thank you everybody for taking the time to join our call. I appreciate it. Take care.

Operator
Operator

[Operator Closing Remarks]